Clinical Trial Update: Expanded Access Program for OOS Obe-cel

View source ↗

Summary

Autolus Limited announced an Expanded Access Program for Obe-cel, its CAR-T therapy, to treat adults with acute lymphoblastic leukemia, including B-cell ALL. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• obe-cel

Snippet

Sponsor: Autolus Limited | Conditions: Lymphoblastic Leukemia, Acute, Adult, B Cell ALL | Status: AVAILABLE